Latest news
{{'2026-06-26T13:01:00Z' | dateFormatFilter}}
Novo Nordisk to showcase new data across its haemophilia portfolio at the ISTH Congress 2026, featuring investigational denecimig
{{'2026-06-11T15:30:50Z' | dateFormatFilter}}
Novo Nordisk A/S: IT Security incident at Novo Nordisk
{{'2026-06-11T15:03:13Z' | dateFormatFilter}}
Novo Nordisk: Wegovy® pill (semaglutide tablets) becomes first daily GLP-1 weight-loss pill approved in the UK
Stay informed
Stay informed
Be the first one to read our company announcements and press releases. Sign up to Novo Nordisk News.
